Affinity DataIC50: 3nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair
Affinity DataIC50: 24nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair
Affinity DataIC50: 29nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair
Affinity DataIC50: 35nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair
Affinity DataIC50: 51nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair
Affinity DataIC50: 117nMT: 2°CAssay Description:Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in...More data for this Ligand-Target Pair